HRA Pharma Rare Diseases (now part of Esteve)

Stand 6

By partnering with your extraordinary community, HRA Pharma Rare Diseases (now part of Esteve) has a personal commitment to playing our part in tackling current challenges, reducing the time to accurate diagnosis, enabling global access to treatment, and optimising long-term management. We share your purpose: to improve quality of life and the experience of care for families affected by rare diseases. On July 10^th, 2024, ESTEVE, a global pharmaceutical company headquartered in Barcelona, Spain, successfully completed the acquisition of HRA Pharma Rare Diseases. This acquisition brings together two experts in the healthcare industry, unified by a shared commitment to addressing unmet medical needs. With our combined assets, we are well-positioned to accelerate our mission of providing solutions to patients around the world.